October 20, 2022 — A team of Case Western Reserve University scientists has received a four-year, $3.7 million National Institutes of Health grant to attempt what they say would be a medical first: performing robotic heart catheterization while the patient is inside a magnetic resonance imaging (MRI) machine. 

October 20, 2022 — Cardiogenic shock—a life threatening condition when a person’s heart can’t pump enough blood to meet the needs of the body—is most often caused by serious heart attack or advanced heart failure. Historically, data related to cardiogenic shock have been limited, inconsistent and challenging to interpret. As a result, varying treatment recommendations exist around best practices. 

October 19, 2022 — Mount Sinai Health System’s globally acclaimed cardiologist Valentin Fuster, MD, PhD, has been named President of Mount Sinai Heart, a newly created position, effective Sunday, January 1, 2023.

October 19, 2022 — For men and women, the risk factors for cardiovascular disease are largely the same, an extensive global study involving University of Gothenburg researchers shows. 

AI & Engineered Tissues for Cardiac Disease Therapeutics Conference

October 18, 2022 —  Foldax, Inc. announced that medtech veteran Gregory D. Casciaro has been named Chief Executive Officer of the company, effective yesterday. In his more than 30 years in the medical technology arena, Casciaro has developed a track record of success leading and growing both private and public companies, from clinical through commercial phases, and from fundraising through acquisitions.

October 18, 2022 —  The United States Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed for its Impella Low

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now